S1963 Among Patients With Crohn's Disease Who Have Failed Anti-TNF Therapy, What Are the Efficacy and Safety Outcomes of Switching to Ustekinumab Compared to Vedolizumab?
Year: 2025
Type: conference-abstract
Authors: Maher Taha, Lana Dardari, Arthur CHIDI Igbo, Amna Naveed Butt, Angelin Raju
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4417196493
Cites:
Cited by:
Related to: